Mycophenolate mofetil CAS 128794-94-5

CAS: 128794-94-5
Pureza: 99%
Molecular Formula: C23H31NO7
Molecular Weight: 433.49
EINECS: /
Tiempo de almacenamiento: 2 años

Synonyms: 2-morpholinoethyl(E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1H-isobenzofuran-5-yl)-4-methyl-hex-4-enoate; 2-morpholinoethyl6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1H-isobenzofuran-5-yl)-4-methyl-hex-4-enoate; 6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1H-isobenzofuran-5-yl)-4-m; (4E)-6-(1,3-Dihydro-4-hydroxy-6-methoxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-4-hexenoicacid2-morpholin-4-ylethylester; Linfonex; 2-Morpholinoethyl(4E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoate; (E)-2-Morpholinoethyl6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1,3-dihydroisobenzofuran-5-yl)-4-m; 2-morpholin-4-ylethyl(e)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1h-isobenzofuran-5-yl)-4-methyl-hex-4-enoate

Mycophenolate mofetil CAS 128794-94-5
Rellena este campo
Por favor, introduce una dirección de correo electrónico válida.
Rellena este campo
Rellena este campo
Rellena este campo
Tienes que aprobar los términos para continuar

What is Mycophenolate mofetil CAS 128794-94-5?

Mycophenolate mofetil is a precursor of active mycophenolic acid (MPA), an immunosuppressive component extracted from the culture fluid of Penicillium. It is an inhibitor of inosine mononucleotide dehydrogenase (IMPDH), which is necessary for the synthesis of guanine nucleotides, especially for the classical synthesis of guanine nucleotides required by lymphocytes.

Especificación

ELEMENTO ESTÁNDAR
Apariencia Polvo cristalino blanco
Purity El 99%MIN
La humedad El ≤0.5%
Total number of oxygen bacteria ≤100 CFU/g

Aplicación

Mycophenolate mofetil used in organ transplantation and can also be used to treat autoimmune myasthenia gravis.

Embalaje

25KG/DRUM

Mycophenolate mofetil CAS 128794-94-5-Pack-2

Mycophenolate mofetil CAS 128794-94-5
Rellena este campo
Por favor, introduce una dirección de correo electrónico válida.
Rellena este campo
Rellena este campo
Rellena este campo
Tienes que aprobar los términos para continuar

También te puede gustar